D68.61

Applicable To

• Anticardiolipin syndrome

• Antiphospholipid antibody syndrome

Approximate Synonyms

• Anticardiolipin syndrome

• Antiphospholipid syndrome complication in pregnancy

• Antiphospholipid syndrome in childbirth

• Antiphospholipid syndrome in pregnancy

• Antiphospholipid syndrome postpartum

• Postpartum after childbirth) antiphospholipid syndrome

• Primary antiphospholipid syndrome

• Secondary antiphospholipid syndrome

Clinical Information

• A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids.

• Associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses; involves the presence of antibodies directed against phospholipids; cardiolipins show markedly elevated levels of anticardiolipin antibodies; present also are high levels of lupus anticoagulant; in pregnancy it can cause abortion.

• The presence of antibodies directed against phospholipids antibodies, antiphospholipid). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies antibodies, anticardiolipin). Present also are high levels of lupus anticoagulant lupus coagulation inhibitor).

Details

• D68.61 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM D68.61 became effective on October 1, 2022.

• This is the American ICD-10-CM version of D68.61 – other international versions of ICD-10 D68.61 may differ.